Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.
D000328:Adult; D000368:Aged; D001262:Atenolol / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000097:blood* / Q000652:urine; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood* / Q000188:drug therapy / Q000652:urine; D008297:Male; D008875:Middle Aged; D011187:Posture; D011412:Propanolamines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D011412:Propanolamines; D014284:Triiodothyronine; D001262:Atenolol; D011433:Propranolol; D000242:Cyclic AMP; D013974:Thyroxine